Congress
Senators Reintroduce Bill to Establish Medicare Coverage Pathway for MCED Tests
The bill would allow Medicare to cover MCED tests following approval by FDA and ensure their use would not impact coverage of traditional screenings.
Decade After SCOTUS Gene Patents Ruling, Precision Medicine and Test Innovation Impact Under Debate
Premium
While some say that striking down gene patents opened up the genetic testing market and patient access, others see greater uncertainty about patent rights and reduced investment.
Critics of the bill suggested that it would allow patents on pathogen genetic material, which could hamper the ability to test and treat in future pandemics.
ACMG Survey Finds Laboratory Geneticists Have Concerns Over Proposed Changes to LDT Regulation
Lab geneticists are raising concerns as the US Congress is expected to take up a bill that would change how the Food and Drug Administration oversees LDTs.
The Right Drug Dose Now Act seeks to address many of the barriers that have hindered integration of pharmacogenomic information into mainstream care.